Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial

PURPOSE: Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high locoregional failure (LRF) rates after definitive chemoradiation (CRT), associated with anogenital human papilloma virus, and often appears in HIV infection. Because cetuximab enhances the effect of radiation therapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Sparano, Joseph A., Lee, Jeannette Y., Palefsky, Joel, Henry, David H., Wachsman, William, Rajdev, Lakshmi, Aboulafia, David, Ratner, Lee, Fitzgerald, Thomas J., Kachnic, Lisa, Mitsuyasu, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455422/
https://ncbi.nlm.nih.gov/pubmed/27937092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.69.1642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados